• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Google Acquires Eye Tracking Startup Eyefluence for VR/AR Focus

by HITC Staff 10/25/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

eyefluence

Google has acquired Eyefluence, an eye-interaction technology for AR, VR, and MR devices which transforms intent into action through the eyes. Financial terms of the acquisition were not disclosed. To date, the company has raised $21.6 million from Motorola Solutions Venture Capital, with participation from NHN Investment, Dolby Family Ventures, and Jazz Venture Partners. 

Traditional eye-tracking companies have tried to translate eye movement into a method for control using the same principles as the standard mouse, requiring users to wait and wink on objects to initiate action. This makes eye-tracking slow, unsatisfying, and straining – and it sacrifices concentration and vision for machine manipulation. Founded in 2013 by serial entrepreneur Jim Margraff, Eyefluence has developed the first user interface based on the eye-brain connection to enable vision-driven, intuitive eye-interaction. The Eyefluence iUi combines biology and technology and integrates into any AR, VR, or MR platform.

The acquisition validates Google’s interest into augmented reality and virtual reality apps. Google did not release any details on how it plans to integrate Eyefluence into its portfolio of products, services and features; however, Google could potentially use the intellectual property to further develop its smart contact lens for diabetes.

In 2015, the U.S. Patent & Trademark Office granted Google a patent for a “smart contact lens having an uneven embedded substrate and method of manufacture.” Many believe the smart contact lens patent could be used to monitor a wearer’s blood sugar levels. 

In blog post announcement Eyefluence stated:

“In early 2013, our journey began with a mission to transform intent into action through your eyes. We recognized an opportunity to create a more natural, intuitive way to interact with augmented and virtual reality displays. Over the last three and a half years we have built an incredible team, advanced our eye-interaction technology, and created strong partnerships that have lead to the development of a completely new language for eye-interaction”

“Today, we are excited to announce that the Eyefluence team is joining Google!  With our forces combined, we will continue to advance eye-interaction technology to expand human potential and empathy on an even larger scale.  We look forward to the life-changing innovations we’ll create together!”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |